Podoplanin inhibitors mitigated the pathological changes after cerebral ischemia-reperfusion in a mouse model of middle cerebral artery occlusion-induced stroke, which indicates a potential role of the CLEC-2/podoplanin axis in thromboinflammation (47). This evidence concerns the gene PDPN and brain ischemia.